Glucotrack issues 2.75M shares after cashless warrant exchange

Glucotrack, Inc.

Exchange of 2,835,905 Series B warrants on March 11, 2025 resulted in 2,749,817 new common shares.
Warrants held by director-affiliated investor and other holders; exercised cashless with no additional consideration.
Issuance exempt under Section 3(a)(9) of Securities Act; no commissions paid.
Follows prior conversion of $4.4M in July notes and July 2024 debt into shares and warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.